Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mehmet Asim Bilen"'
Autor:
Sandy T. Liu, Vadim S. Koshkin, Jayanshu Jain, Monika Joshi, Matthew D. Galsky, Noah M. Hahn, Lucia Alonso Buznego, Marcus Marie Moses, Jure Murgic, Ali Raza Khaki, Tyler F. Stewart, Aristotelis Bamias, Guru Sonpavde, Daniel Castellano, Evan Shreck, Joseph J. Park, Ajjai Alva, Mehmet Asim Bilen, Alexandra Drakaki, Yousef Zakharia, Mark P. Lythgoe, Ariel Ann Nelson, Roubini Zakopoulou, Ang Li, Ivan de Kouchkovsky, Rafael Morales-Barrera, Petros Grivas, Veena Shankaran, Christopher J. Hoimes, Vivek Kumar, Pedro Isaacsson Velho, Ignacio Duran, Abhishek Tripathi, Leonidas Nikolaos Diamantopoulos, Michael Edward Devitt, Pedro C. Barata, Ana Fröbe, Lucia Carril-Ajuria, Evan Y. Yu, Alejo Rodriguez-Vida, Victor Sacristan Santos, Neeraj Agarwal, Alexander Sankin, Benjamin A. Gartrell, Gary H. Lyman, David J. Pinato, Natalie J. Miller
Publikováno v:
Eur Urol Oncol
European urology oncology, vol 4, iss 3
European urology oncology, vol 4, iss 3
Background: While immune checkpoint inhibitors (ICIs) are approved in the first-line (1L) setting for cisplatin-unfit patients with programmed death-ligand 1 (PD-L1)-high tumors or for platinum (cisplatin/carboplatin)-unfit patients, response rates r